LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

LLY

1,061.04

+3.27%↑

JNJ

214.42

+1.41%↑

ABBV

227.63

+1.87%↑

UNH

341.44

+0.01%↑

AZN

91.59

+2%↑

Inicio・Lista de Acciones・Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc

Cerrado

SectorSanidad

43.73 -0.59

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

43.34

Máximo

44.1

Métricas clave
By Trading Economics
Ingresos	-6.2M -91M
Margen de beneficios	-867.293
Empleados	316
EBITDA	4M -90M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+24.74% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	211M 3.4B
Apertura anterior	44.32
Cierre anterior	43.73

Noticias sobre sentimiento de mercado

By Acuity

50%

165 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bearish Evidence

34.81 / 38.24 Soporte y Resistencia

Xenon Pharmaceuticals Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

15 dic 2025, 17:39 UTC

Principales Movimientos del Mercado

Vanda Pharmaceuticals Rises on FDA Biologics License Application

15 dic 2025, 23:44 UTC

Charlas de Mercado

Gold Steady Ahead of U.S. Employment Report -- Market Talk

15 dic 2025, 23:38 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

15 dic 2025, 23:38 UTC

Charlas de Mercado

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

15 dic 2025, 22:19 UTC

Charlas de Mercado

Clean-Energy Project Developers Benefit From 'Deep Buyer Universe' -- Market Talk

15 dic 2025, 21:50 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

15 dic 2025, 21:42 UTC

Adquisiciones, fusiones, absorciones

Comcast Spinoff Versant Debuts at Modest Valuation, a Signal for a Warner Bros. Sale -- Barrons.com

15 dic 2025, 21:32 UTC

Adquisiciones, fusiones, absorciones

Comcast Spinoff Versant Debuts at Modest Valuation, Puts Warner Bros. Discovery in Focus -- Barrons.com

15 dic 2025, 21:28 UTC

Adquisiciones, fusiones, absorciones

iRobot Files for Bankruptcy After Amazon Was Forced to Scrap Its Deal to Buy the Roomba Maker -- Barrons.com

15 dic 2025, 21:26 UTC

Adquisiciones, fusiones, absorciones

Commercial Metals Completes Acquisition of Foley Products for $1.84B >CMC

15 dic 2025, 21:23 UTC

Adquisiciones, fusiones, absorciones

Perseus Mining: Reserves Right to Make Further Proposal If Circumstances Change

15 dic 2025, 21:23 UTC

Adquisiciones, fusiones, absorciones

Perseus Mining: Does Not Intend to Submit Revised Takeover Proposal For Predictive

15 dic 2025, 21:23 UTC

Adquisiciones, fusiones, absorciones

Perseus Mining: Notes Predictive Shares Trade at Discount to Value Implied By Perseus Proposal

15 dic 2025, 21:22 UTC

Adquisiciones, fusiones, absorciones

Perseus Mining: Believes Revised Robex Merger Inferior to Its Own Takeover Proposal

15 dic 2025, 21:20 UTC

Adquisiciones, fusiones, absorciones

Commercial Metals Completes Acquisition Of Foley Products Company >CMC

15 dic 2025, 21:15 UTC

Adquisiciones, fusiones, absorciones

ServiceNow Completes Acquisition Of Moveworks >NOW

15 dic 2025, 21:00 UTC

Adquisiciones, fusiones, absorciones

Comcast Spinoff Versant Debuts at Low Valuation; Could Figure in Warner Bros. Discovery Takeover Battle -- Barrons.com

15 dic 2025, 20:57 UTC

Adquisiciones, fusiones, absorciones

Comcast Spinoff Versant Debuts at Low Valuation; Could Figure in Warner Bros. Discovery Takeover Battle -- Barrons.com

15 dic 2025, 20:36 UTC

Charlas de Mercado

Oil Futures Fall Further on Oversupply Concerns -- Market Talk

15 dic 2025, 20:31 UTC

Charlas de Mercado

U.S. Natural Gas Futures Extend Losing Streak -- Market Talk

15 dic 2025, 20:27 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

ServiceNow's Acquisition Streak Could Cause Investor Angst -- Market Talk

15 dic 2025, 20:15 UTC

Charlas de Mercado

El Buen Fin Helps Lift Mexican November Retail Sales -- Market Talk

15 dic 2025, 19:22 UTC

Charlas de Mercado

Gold and Silver Gain to Start Week -- Market Talk

15 dic 2025, 18:37 UTC

Charlas de Mercado

Oil Futures Extend Losses On Oversupply Worries -- Market Talk

15 dic 2025, 18:29 UTC

Charlas de Mercado

ServiceNow Seen Facing Pressure if Government Budgets Decline -- Market Talk

15 dic 2025, 17:58 UTC

Charlas de Mercado

Canada Housing Market In Search Of a Bottom -- Market Talk

15 dic 2025, 17:36 UTC

Charlas de Mercado

Canada Data Signal Underlying Price Pressures Persist -- Market Talk

15 dic 2025, 17:36 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

15 dic 2025, 17:36 UTC

Ganancias

Texas Instruments Stock Slips. It Caught a Rare Downgrade From Goldman Sachs. -- Barrons.com

15 dic 2025, 17:30 UTC

Adquisiciones, fusiones, absorciones

Cinemark Stock Could Fall Even More If Netflix Buys Warner Bros., Analyst Says -- Barrons.com

Comparación entre iguales

Cambio de precio

Xenon Pharmaceuticals Inc previsión

Precio Objetivo

By TipRanks

24.74% repunte

Estimación a 12 Meses

Media 54.96 USD 24.74%

Máximo 65 USD

Mínimo 44 USD

De acuerdo con 15 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Xenon Pharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

15 ratings

Comprar

Mantener

Vender

De acuerdo con 15 analistas que ofrecen calificaciones bursátiles a para Xenon Pharmaceuticals Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

34.81 / 38.24Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

The bullish and bearish events are balanced.

Sentimiento

By Acuity

165 / 374 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN1101, a novel and potent Kv7 potassium channel opener, which is in Phase 3 clinical trials for the treatment of epilepsy and other neurological disorders. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase 2 clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.